ClinicalTrials.Veeva

Menu
V

Victorium Clinical Research | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
TAK-279
Sugar
Icotrokinra
NNC0487-0111
BI 690517
Vicadrostat
Finerenone
Elismetrep
Verekitug

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 14 total trials

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.

Not yet enrolling
Acute Migraine
Drug: Placebo
Drug: Elismetrep

The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and ado...

Enrolling
Colitis, Ulcerative
Drug: Icotrokinra
Drug: Placebo
Locations recently updated

This study is being done to look at the safety and effect of NNC0487-0111 in people with Heart Failure with preserved Ejection Fraction (HFpEF) or He...

Enrolling
Obesity
Heart Failure
Drug: NNC0487-0111
Drug: Placebo

The purpose of this study is to evaluate how-well icotrokinra works (clinical efficacy) and how safe it is (safety) in participants with moderately t...

Enrolling
Crohn Disease
Drug: Icotrokinra
Drug: Placebo

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate t...

Enrolling
Crohn's Disease
Drug: Placebo
Drug: TAK-279

The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical...

Active, not recruiting
Ulcerative Colitis
Drug: TAK-279
Drug: Placebo

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Other: Placebo
Drug: Verekitug
Locations recently updated

This is a double-blind, randomized, multicenter, outpatient evaluation of the efficacy, safety, and tolerability of elismetrep, as compared with plac...

Enrolling
Migraine
Drug: Placebo
Drug: Elismetrep

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat

Trial sponsors

Novo Nordisk logo
Janssen (J&J Innovative Medicine) logo
K
Takeda logo
Bayer logo
Boehringer Ingelheim logo
Mylan logo
Pfizer logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems